佐林格-埃利森综合征：最新进展与争议
Zollinger-Ellison syndrome: recent advances and controversies.
机构信息
aDepartment of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Higashi-ku, Fukuoka, Japan bDigestive Diseases Branch, NIDDK, NIH, Bethesda, Maryland, USA.
出版信息
Curr Opin Gastroenterol. 2013 Nov;29(6):650-61. doi: 10.1097/MOG.0b013e328365efb1.
Abstract
PURPOSE OF REVIEW
To review the recent advances and current controversies in patients with Zollinger-Ellison syndrome (ZES).
RECENT FINDINGS
Recent advances in the management of ZES include: improved understanding of the pathogenesis of gastrinoma and pancreatic neuroendocrine tumors, new prognostic classification systems, new diagnostic algorithms, more sensitive localization studies, new treatment strategies including improved control of gastric acid secretion and role for surgery, and new approaches to patients with advanced disease. Controversies include: the best approach to a patient with hypergastrinemia suspected of possibly having ZES, the appropriate gastrin assay to use, the role of surgery in patients with ZES, especially those with multiple endocrine neoplasia type 1, and the precise order of therapeutic modalities in the treatment of patients with advanced disease.
SUMMARY
This review updates clinicians regarding important advances and controversies required to optimally diagnose and manage patients with ZES.
摘要
目的综述
回顾 Zollinger-Ellison 综合征（ZES）患者的最新进展和当前争议。
最近的发现
ZES 管理方面的最新进展包括：对胃泌素瘤和胰腺神经内分泌肿瘤发病机制的理解加深、新的预后分类系统、新的诊断算法、更敏感的定位研究、新的治疗策略，包括胃酸分泌控制的改善和手术的作用，以及晚期疾病患者的新方法。争议包括：对疑似可能患有 ZES 的高胃泌素血症患者的最佳处理方法、使用的适当胃泌素检测方法、手术在 ZES 患者中的作用，尤其是多发性内分泌肿瘤 1 型患者，以及晚期疾病患者治疗中治疗方式的精确顺序。
总结
本综述使临床医生了解诊断和治疗 ZES 患者所需的重要进展和争议，以达到最佳效果。
相似文献
1
Zollinger-Ellison syndrome: recent advances and controversies.佐林格-埃利森综合征：最新进展与争议
Curr Opin Gastroenterol. 2013 Nov;29(6):650-61. doi: 10.1097/MOG.0b013e328365efb1.
2
All you need to know about gastrinoma today | Gastrinoma and Zollinger-Ellison syndrome: A thorough update.今日关于胃泌素瘤你需要了解的一切 | 胃泌素瘤与卓-艾综合征：全面更新
J Neuroendocrinol. 2023 Apr;35(4):e13267. doi: 10.1111/jne.13267. Epub 2023 Apr 11.
3
Gastrinoma and Zollinger Ellison syndrome: A roadmap for the management between new and old therapies.胃泌素瘤和卓-艾综合征：新旧疗法管理之间的路线图。
World J Gastroenterol. 2021 Sep 21;27(35):5890-5907. doi: 10.3748/wjg.v27.i35.5890.
4
Serum gastrin in Zollinger-Ellison syndrome: I. Prospective study of fasting serum gastrin in 309 patients from the National Institutes of Health and comparison with 2229 cases from the literature.佐林格-埃利森综合征中的血清胃泌素：I. 对美国国立卫生研究院309例患者空腹血清胃泌素的前瞻性研究，并与文献中的2229例病例进行比较。
Medicine (Baltimore). 2006 Nov;85(6):295-330. doi: 10.1097/01.md.0000236956.74128.76.
5
[Diagnostic and therapeutic strategies in Zollinger-Ellison syndrome associated with multiple endocrine neoplasia type I (MEN-I): experience of the Zollinger-Ellison Syndrome Research Group: Bichat 1958-1999].[与I型多发性内分泌腺瘤病（MEN-I）相关的佐林格-埃利森综合征的诊断和治疗策略：佐林格-埃利森综合征研究组的经验：比夏特1958 - 1999年]
Bull Acad Natl Med. 2003;187(7):1249-58; discussion 1259-60.
6
The effect of Zollinger-Ellison syndrome and neuropeptide-secreting tumors on the stomach.卓-艾综合征和神经肽分泌肿瘤对胃的影响。
Curr Gastroenterol Rep. 1999 Dec;1(6):511-7. doi: 10.1007/s11894-999-0012-8.
7
Current diagnosis and management of Zollinger-Ellison syndrome.卓-艾综合征的当前诊断与管理
Ann Surg. 1989 Dec;210(6):685-703. doi: 10.1097/00000658-198912000-00001.
8
Gastrinoma: advances in localization and treatment.胃泌素瘤：定位与治疗进展
Surg Oncol Clin N Am. 1998 Oct;7(4):845-61.
9
Prospective study of the standard meal provocative test in Zollinger-Ellison syndrome.卓-艾综合征标准餐激发试验的前瞻性研究。
Am J Med. 1989 Nov;87(5):528-36. doi: 10.1016/s0002-9343(89)80609-6.
10
Zollinger-Ellison syndrome. Advances in treatment of gastric hypersecretion and the gastrinoma.
JAMA. 1994 May 11;271(18):1429-35. doi: 10.1001/jama.271.18.1429.
引用本文的文献
1
Long-Term Proton Pump Inhibitor-Acid Suppressive Treatment Can Cause Vitamin B Deficiency in Zollinger-Ellison Syndrome (ZES) Patients.长期质子泵抑制剂抑酸治疗可导致 Zollinger-Ellison 综合征（ZES）患者维生素 B 缺乏。
Int J Mol Sci. 2024 Jul 2;25(13):7286. doi: 10.3390/ijms25137286.
2
Personalized treatment of well-differentiated gastric neuroendocrine tumors based on clinicopathological classification and grading: A multicenter retrospective study.基于临床病理分类和分级的胃神经内分泌肿瘤的个体化治疗：一项多中心回顾性研究。
Chin Med J (Engl). 2024 Mar 20;137(6):720-728. doi: 10.1097/CM9.0000000000003029. Epub 2024 Feb 22.
3
Esophageal Perforation Unveiling the Diagnosis of Zollinger-Ellison Syndrome.食管穿孔揭示卓-艾综合征的诊断
J Community Hosp Intern Med Perspect. 2023 Sep 2;13(5):77-81. doi: 10.55729/2000-9666.1228. eCollection 2023.
4
Relation between WHO Classification and Location- and Functionality-Based Classifications of Neuroendocrine Neoplasms of the Digestive Tract.消化系统神经内分泌肿瘤的 WHO 分类与基于位置和功能的分类之间的关系。
Neuroendocrinology. 2024;114(2):120-133. doi: 10.1159/000534035. Epub 2023 Sep 8.
5
Severe ectopic Cushing syndrome in a transgender man with a metastatic gastrinoma and an adrenal tumor-A case report and review of the literature.一名转移性胃泌素瘤和肾上腺肿瘤的跨性别男性出现严重异位库欣综合征：病例报告及文献复习。
Front Endocrinol (Lausanne). 2023 Mar 16;14:1135016. doi: 10.3389/fendo.2023.1135016. eCollection 2023.
6
Quantitative characterization of duodenal gastrinoma autofluorescence using multiphoton microscopy.采用多光子显微镜对十二指肠胃泌素瘤自发荧光进行定量表征。
Lasers Surg Med. 2023 Feb;55(2):208-225. doi: 10.1002/lsm.23619. Epub 2022 Dec 14.
7
Sporadic and MEN1-related gastrinoma and Zollinger-Ellison syndrome: differences in clinical characteristics and survival outcomes.散发性和 MEN1 相关性胃泌素瘤和卓-艾综合征：临床特征和生存结局的差异。
J Endocrinol Invest. 2023 May;46(5):957-965. doi: 10.1007/s40618-022-01961-w. Epub 2022 Nov 27.
8
Updated Principles of Surgical Management of Pancreatic Neuroendocrine Tumours (pNETs): What Every Surgeon Needs to Know.胰腺神经内分泌肿瘤（pNETs）手术管理的更新原则：每位外科医生都需要了解的内容。
Cancers (Basel). 2021 Nov 27;13(23):5969. doi: 10.3390/cancers13235969.
9
Gastrinoma and Zollinger Ellison syndrome: A roadmap for the management between new and old therapies.胃泌素瘤和卓-艾综合征：新旧疗法管理之间的路线图。
World J Gastroenterol. 2021 Sep 21;27(35):5890-5907. doi: 10.3748/wjg.v27.i35.5890.
10
JNETS clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms: diagnosis, treatment, and follow-up: a synopsis.JNETS 胃肠胰神经内分泌肿瘤临床实践指南：诊断、治疗和随访：概要。
J Gastroenterol. 2021 Nov;56(11):1033-1044. doi: 10.1007/s00535-021-01827-7. Epub 2021 Sep 29.
本文引用的文献
1
Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors.1型多发性内分泌腺瘤病的死亡原因及预后因素：一项前瞻性研究：106例MEN1/卓艾综合征患者与1613例有或无胰腺内分泌肿瘤的文献报道的MEN1患者的比较
Medicine (Baltimore). 2013 May;92(3):135-181. doi: 10.1097/MD.0b013e3182954af1.
2
Laparoscopic resection for primary lymph node gastrinoma.
Pancreas. 2013 May;42(4):723-5. doi: 10.1097/MPA.0b013e31826dcd52.
3
Consensus guidelines for the management and treatment of neuroendocrine tumors.神经内分泌肿瘤管理与治疗的共识指南。
Pancreas. 2013 May;42(4):557-77. doi: 10.1097/MPA.0b013e31828e34a4.
4
Peptide receptor radionuclide therapy (PRRT) for GEP-NETs.肽受体放射性核素治疗（PRRT）用于胃肠胰腺神经内分泌肿瘤（GEP-NETs）。
Best Pract Res Clin Gastroenterol. 2012 Dec;26(6):867-81. doi: 10.1016/j.bpg.2013.01.004.
5
Selecting patients for cytotoxic therapies in gastroenteropancreatic neuroendocrine tumours.选择胃肠胰神经内分泌肿瘤患者进行细胞毒治疗。
Best Pract Res Clin Gastroenterol. 2012 Dec;26(6):843-54. doi: 10.1016/j.bpg.2012.12.001.
6
Biotherapies for GEP-NETs.胃肠胰腺神经内分泌肿瘤的生物治疗。
Best Pract Res Clin Gastroenterol. 2012 Dec;26(6):833-41. doi: 10.1016/j.bpg.2013.01.001.
7
Surgery for GEP-NETs.胃肠胰神经内分泌肿瘤的外科治疗。
Best Pract Res Clin Gastroenterol. 2012 Dec;26(6):819-31. doi: 10.1016/j.bpg.2012.12.005.
8
Radiological and nuclear medicine imaging of gastroenteropancreatic neuroendocrine tumours.胃肠胰神经内分泌肿瘤的放射学和核医学影像。
Best Pract Res Clin Gastroenterol. 2012 Dec;26(6):803-18. doi: 10.1016/j.bpg.2012.12.004.
9
Pancreatic neuroendocrine tumors: clinical features, diagnosis and medical treatment: advances.胰腺神经内分泌肿瘤：临床特征、诊断和治疗：进展。
Best Pract Res Clin Gastroenterol. 2012 Dec;26(6):737-53. doi: 10.1016/j.bpg.2012.12.003.
10
Gastric and duodenal neuroendocrine tumours.胃和十二指肠神经内分泌肿瘤。
Best Pract Res Clin Gastroenterol. 2012 Dec;26(6):719-35. doi: 10.1016/j.bpg.2013.01.002.
Zotero 插件